Christian B.
- Country
- Germany
- Department
- Institute of Experimental Cancer Research Comprehensive Cancer Center Ulm (CCCU)
Research Overview
- A Phase 2, Open-Label, Multicenter, Basket Study Evaluating the Safety and Efficacy of Brexucabtagene Autoleucel in Adults with Rare B-cell Malignancies (ZUMA-25) – Substudy A – Relapsed/Refractory Waldenstrom Macroglobulinemia
- A Phase 2, Open-Label, Multicenter, Basket Study Evaluating the Safety and Efficacy of Brexucabtagene Autoleucel in Adults with Rare B-cell Malignancies (ZUMA 25) – Substudy B – Relapsed/Refractory Richter Transformation (RT)
- A Phase 2, Open-Label, Multicenter, Basket Study Evaluating the Safety and Efficacy of Brexucabtagene Autoleucel in Adults with Rare B-cell Malignancies (ZUMA-25) – Substudy D - Relapsed/Refractory Hairy Cell Leukemia (HCL)
Data & Insights
Has run more than one trial at 84 of 249 partner sites.
Specializations
Lymphoma Research Focus
This investigator specializes in the treatment of B-cell lymphomas, with particular emphasis on marginal zone lymphoma and follicular lymphoma. Their research encompasses both early-stage disease management and advanced therapeutic approaches.
- Marginal Zone Lymphoma Treatment Innovations
- Early-Stage Follicular Lymphoma Management
- Novel Combination Therapies
Rare Blood Disorders
The investigator has extensive experience in treating Waldenström's Macroglobulinemia and other rare B-cell malignancies including Burkitt lymphoma and hairy cell leukemia.
- Waldenström's Macroglobulinemia Therapeutics
- Rare B-cell Malignancy Treatment
- Advanced Hematologic Disorders
Therapeutic Innovations
This clinician explores cellular therapy approaches and targeted treatments, including novel antibody therapies and innovative drug combinations for blood cancers.
- CAR T-Cell Therapy Applications
- Monoclonal Antibody Treatments
- Combination Therapy Strategies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.